U.S. appeals court upholds ruling invalidating J & J patent on Remicade

(Reuters) - A U.S. appeals court on Tuesday upheld a ruling that invalidated a crucial Johnson& Johnson patent on its blockbuster rheumatoid arthritis drug Remicade, limiting J&J ’s ability to seek damages from Pfizer Inc over its launch of a lower-cost version of the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news